2017 European Ulcerative Colitis Guidelines – Diagnosis – Part One of Two Parts

Resources:

(1) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders [PubMed Citation] [Full Text HTML] [Full Text PDF]. J Crohns Colitis. 2017 Jun 1;11(6):649-670. doi: 10.1093/ecco-jcc/jjx008.

(2) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management [PubMed Citation] [Full Text HTML] [Full Text PDF]. J Crohns Colitis. 2017 Jul 1;11(7):769-784. doi: 10.1093/ecco-jcc/jjx009.

(3) Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management [PubMed Abstract] [Full Text HTML] [Full Text PDF]. Clin Med Insights Gastroenterol. 2016 Jun 9;9:25-9. doi: 10.4137/CGast.S38451. eCollection 2016.

(4) Primary Sclerosing Cholangitis Updated: Nov 20, 2016 from Emedicine/Medscape

(5) Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease [PubMed Abstract] [Full Text HTML] [Full Text PDF]. J Crohns Colitis. 2014 Jun;8(6):443-68. doi: 10.1016/j.crohns.2013.12.013. Epub 2014 Mar 6.

(6) Inflammatory Bowel Disease: Checklist for the prevention of infections [Full Text PDF].

To be kept in each patient’s file.

The objective of this check-list is to provide each gastroenterologist to be considered according to the ECCO guidelines [Resource (1) above] before and during immunomodulary treatment. Ideally, the check list should be completed at the patient’s first visit, or at least before the initiation of immunomodulary treatment. It can be updated at subsequent visits.

This entry was posted in Family Medicine, Gastroenterology, Guidelines, Internal Medicine, Pediatrics. Bookmark the permalink.